Back to MOLN Stock Lookup

(MOLN) – PRNewswire

Mar 17, 2020 04:00 AM Medicxi Bolsters and Expands Team with Senior Industry Leaders
Oct 11, 2019 07:40 PM Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration
Sep 9, 2019 07:30 AM Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-re

Back to MOLN Stock Lookup